...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

narmac

Rank: Vice President [?]

Points: 3973 [?]

Votes: 36 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Sabizabulin - mCRPC- used now for Covid 19.

posted on Apr 13, 2022 06:37AM

Interesting read,,,,small enrollment and the short period of time for the C19 Plll trial. Share price has sky rocketed up!!!

https://www.onclive.com/view/novel-compound-looks-to-shake-up-mcrpc-treatment-landscape

VERU Inc.

Veru’s Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy